Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size

NCT02021942 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Primary Inoperable Thymoma
Local Recurrent Thymoma

Interventions

DRUG: SOM230 LAR

Sponsor

Prof. Dr. Berthold Schalke

Collaborators

[object Object]